Cardiac repolarization during hypoglycaemia and hypoxaemia in healthy males: Impact of renin-angiotensin system activity

Europace

Volumn 10, Issue 2, 2008, Pages 219-226

  Due Andersen, Rikke ^a   Høi Hansen, Thomas ^a   Olsen, Niels Vidiendal ^b   Larroude, Charlotte Ellen ^c,d   Kanters, Jørgen Kim ^c,d   Boomsma, Frans ^e   Pedersen Bjergaard, Ulrik ^a   Thorsteinsson, Birger ^a  

^a HILLERØD HOSPITAL   (Denmark)

^b Mental Health Center Glostrup   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cardiac repolarization; Hypoglycaemia; Hypoxaemia; QT; Renin angiotensin system; Substrate deficiency

Indexed keywords

GLUCOSE; OXYGEN; INSULIN; INSULIN, NEUTRAL; UNCLASSIFIED DRUG;

ARTICLE; DYNAMICS; HEART MUSCLE; HEART REPOLARIZATION; HOLTER MONITORING; HUMAN; HYPOGLYCEMIA; HYPOXEMIA; MALE; OUTCOME VARIABLE; OXYGEN TENSION; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STATISTICAL SIGNIFICANCE; STIMULUS; ADULT; ANOXIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; ELECTROCARDIOGRAPHY; LONG QT SYNDROME; OXYGEN THERAPY; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SINGLE BLIND PROCEDURE;

ADULT; ANOXIA; CROSS-OVER STUDIES; ELECTROCARDIOGRAPHY, AMBULATORY; HUMANS; HYPOGLYCEMIA; INSULIN; LONG QT SYNDROME; MALE; OXYGEN INHALATION THERAPY; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS; SINGLE-BLIND METHOD;

EID: 41949122896     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eum286     Document Type: Article

References (50)

1. Takezako T, Zhang B, Serikawa T, Fan P, Nomoto J, Saku K. The D allele of the angiotensin-converting enzyme gene and reperfusion-induced ventricular arrhythmias in patients with acute myocardial infarction. Jpn Circ J 2001;65:603-9.
2. Domanski MJ, Exner DV, Borkowf CB, Geller NL, Rosenberg Y, Pfeffer MA. Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction. A meta-analysis of randomized clinical trials. J Am Coll Cardiol 1999;33:598-604.
3. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-6.
4. Raizada V, Skipper B, Luo W, Garza L, Hines CW, Harford AA et al. Renin-angiotensin polymorphisms and QTc interval prolongation in end-stage renal disease. Kidney Int 2005;68:1186-9.
5. Gonzalez-Juanatey JR, Garcia-Acuna JM, Pose A, Varela A, Calvo C, Cabezas-Cerrato J et al. Reduction of QT and QTc dispersion during longterm treatment of systemic hypertension with enalapril. Am J Cardiol 1998;81:170-4.
6. Spargias KS, Lindsay SJ, Hall AS, Cowan JC, Ball SG. Ramipril reduces QT dispersion in patients with acute myocardial infarction and heart failure. Am J Cardiol 1999;83:969-71, A10.
7. Straus SM, Kors JA, De Bruin ML, van der Hooft CS, Hofman A, Heeringa J et al. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol 2006;47:362-7.
8. Jensen BT, Abildstrom SZ, Larroude CE, Agner E, Torp-Pedersen C, Nyvad O et al. QT dynamics in risk stratification after myocardial infarction. Heart Rhythm 2005;2:357-64.
9. Pathak A, Curnier D, Fourcade J, Roncalli J, Stein PK, Hermant P et al. QT dynamicity: a prognostic factor for sudden cardiac death in chronic heart failure. Eur J Heart Fail 2005;7:269-75.
10. Extramiana F, Neyroud N, Huikuri HV, Koistinen MJ, Coumel P, Maison-Blanche P. QT interval and arrhythmic risk assessment after myocardial infarction. Am J Cardiol 1999;83:266-9.
11. Lankipalli RS, Zhu T, Guo D, Yan GX. Mechanisms underlying arrhythmogenesis in long QT syndrome. J Electrocardiol 2005;38:69-73.
12. Montgomery HE, Marshall R, Hemingway H, Myerson S, Clarkson P, Dollery C et al. Human gene for physical performance. Nature 1998;393:221-2.
13. Pedersen-Bjergaard U, Agerholm-Larsen B, Pramming S, Hougaard P, Thorsteinsson B. Prediction of severe hypoglycaemia by angiotensinconverting enzyme activity and genotype in type 1 diabetes. Diabetologia 2003;46:89-96.
14. Nordfeldt S, Samuelsson U. Serum ACE predicts severe hypoglycemia in children and adolescents with type 1 diabetes. Diabetes Care 2003;26:274-8.
15. Pedersen-Bjergaard U, Dhamrait S, Montgomery H, Pramming S, Thorsteinsson B. Angiotensin II receptor polymorphims and occurence of severe hypoglycemia in type 1 diabetes. (Abstract). Diabetes 2003;52(Suppl. 1): A29.
16. Pedersen-Bjergaard U, Sethi AA, Frandsen E, Hougaard P, Pramming S, Thorsteinsson B. Synergistic effect of plasma angiotensinogen and ACE-activity on risk of severe hypoglycaemia in type 1 diabetes. (Abstract). Diabetologia 2002;45:A78.
17. Warnecke C, Mugrauer P, Surder D, Erdmann J, Schubert C, Regitz-Zagrosek V. Intronic ANG II type 2 receptor gene polymorphism 1675 G/A modulates receptor protein expression but not mRNA splicing. Am J Physiol Regul Integr Comp Physiol 2005;289:R1729-35.
18. Laguna P, Thakor NV, Caminal P, Jane R, Yoon HR, Bayes de LA et al. New algorithm for QT interval analysis in 24-hour Holter ECG: performance and applications. Med Biol Eng Comput 1990;28:67-73.
19. Derkx FH, Steunkel C, Schalekamp MP, Visser W, Huisveld IH, Schalekamp MA. Immunoreactive renin, prorenin, and enzymatically active renin in plasma during pregnancy and in women taking oral contraceptives. J Clin Endocrinol Metab 1986;63:1008-15.
20. van der Hoorn FA, Boomsma F, Man in 't Veld AJ, Schalekamp MA. Determination of catecholamines in human plasma by high-performance liquid chromatography: comparison between a new method with fluorescence detection and an established method with electrochemical detection. J Chromatogr 1989;487:17-28.
21. Robinson RT, Harris ND, Ireland RH, Lee S, Newman C, Heller SR. Mechanisms of abnormal cardiac repolarization during insulin-induced hypoglycemia. Diabetes 2003;52:1469-74.
22. Chevalier P, Burri H, Adeleine P, Kirkorian G, Lopez M, Leizorovicz A et al. QT dynamicity and sudden death after myocardial infarction: results of a long-term follow-up study. J Cardiovasc Electrophysiol 2003;14:227-33.
23. Waernbaum I, Blohme G, Ostman J, Sundkvist G, Eriksson JW, Arnqvist HJ et al. Excess mortality in incident cases of diabetes mellitus aged 15 to 34 years at diagnosis: a population-based study (DISS) in Sweden. Diabetologia 2006;49:653-9.
24. Pedersen-Bjergaard U, Pramming S, Heller SR, Wallace TM, Rasmussen AK, Jorgensen HV et al. Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection. Diabetes Metab Res Rev 2004;20:479-86.
25. Tattersall RB, Gill GV. Unexplained deaths of type 1 diabetic patients. Diabet med 1991;8:49-58.
26. Marques JL, George E, Peacey SR, Harris ND, Macdonald IA, Cochrane Tet al. Altered ventricular repolarization during hypoglycaemia in patients with diabetes. Diabet med 1997;14:648-54.
27. Lieb W. Impact of diabetes on QT dynamicity in patients with and without myocardial infarction: the KORA family heart study. Pacing Clin Electrophysiol 2007;30:S183-7.
28. Valensi PE, Johnson NB, Maison-Blanche P, Extramania F, Motte G, Coumel P. Influence of cardiac autonomic neuropathy on heart rate dependence of ventricular repolarization in diabetic patients. Diabetes Care 2002;25:918-23.
29. Yue DT, Herzig S, Marban E. Beta-adrenergic stimulation of calcium channels occurs by potentiation of high-activity gating modes. Proc Natl Acad Sci USA 1990;87:753-7.
30. Shimizu W, Antzelevitch C. Cellular basis for the ECG features of the LQT1 form of the long-QT syndrome: effects of beta-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes. Circulation 1998;98:2314- 22.
31. Yan GX, Antzelevitch C. Cellular basis for the normal Twave and the electrocardiographic manifestations of the long-QT syndrome. Circulation 1998;98:1928-36.
32. Yan GX, Wu Y, Liu T, Wang J, Marinchak RA, Kowey PR. Phase 2 early afterdepolarization as a trigger of polymorphic ventricular tachycardia in acquired long-QT syndrome: direct evidence from intracellular recordings in the intact left ventricular wall. Circulation 2001;103:2851-6.
33. Watanabe T, Delbridge LM, Bustamante JO, McDonald TF. Heterogeneity of the action potential in isolated rat ventricular myocytes and tissue. Circ Res 1983;52:280-90.
34. Clark RB, Bouchard RA, Salinas-Stefanon E, Sanchez-Chapula J, Giles WR. Heterogeneity of action potential waveforms and potassium currents in rat ventricle. Cardiovasc Res 1993;27:1795-9.
35. Kanters JK, Graff C, Andersen MP, Hardahl T, Toft E, Christiansen M et al. Long QT syndrome genotyping by electrocardiography: fact, fiction, or something in between? J Electrocardiol 2006;39:S119-S122.
36. Numaguchi H, Johnson JP Jr, Petersen CI, Balser JR. A sensitive mechanism for cation modulation of potassium current. Nat Neurosci 2000;3:429-30.
37. Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med 2004;350:1013-22.
38. Zeltser D, Justo D, Halkin A, Prokhorov V, Heller K, Viskin S. Torsade de pointes due to noncardiac drugs: most patients have easily identifiable risk factors. Medicine (Baltimore) 2003;82:282-90.
39. Camm AJ, Janse MJ, Roden DM, Rosen MR, Cinca J, Cobbe SM. Congenital and acquired long QT syndrome. Eur Heart J 2000;21:1232-7.
40. Aulbach F, Simm A, Maier S, Langenfeld H, Walter U, Kersting U et al. Insulin stimulates the L-type Ca2+ current in rat cardiac myocytes. Cardiovasc Res 1999;42:113-20.
41. Zhang Y, Han H, Wang J, Wang H, Yang B, Wang Z. Impairment of human ether-a-go-go-related gene (HERG) K+ channel function by hypoglycemia and hyperglycemia. Similar phenotypes but different mechanisms. J Biol Chem 2003;278:10417-26.
42. Extramiana F, Maison-Blanche P, Tavernier R, Jordaens L, Leenhardt A, Coumel P. Cardiac effects of chronic oral beta-blockade: lack of agreement between heart rate and QT interval changes. Ann Noninvasive Electrocardiol 2002;7:379-88.
43. Roche F, Reynaud C, Pichot V, Duverney D, Costes F, Garet M et al. Effect of acute hypoxia on QT rate dependence and corrected QT interval in healthy subjects. Am J Cardiol 2003;91:916-9.
44. Kiely DG, Cargill RI, Grove A, Struthers AD, Lipworth BJ. Abnormal myocardial repolarisation in response to hypoxaemia and fenoterol. Thorax 1995;50:1062-6.
45. Hool LC. Acute hypoxia differentially regulates K(+) channels. Implications with respect to cardiac arrhythmia. Eur Biophys J 2005;34:369-76.
46. Lin C, Cvetanovic I, Ke X, Ranade V, Somberg J. A mechanism for the potential proarrhythmic effect of acidosis, bradycardia, and hypokalemia on the blockade of human ether-a-go-go-related gene (HERG) channels. Am J Ther 2005;12:328-36.
47. Tavernier R, Jordaens L, Haerynck F, Derycke E, Clement DL. Changes in the QT interval and its adaptation to rate, assessed with continuous electrocardiographic recordings in patients with ventricular fibrillation, as compared to normal individuals without arrhythmias. Eur Heart J 1997;18:994-9.
48. Jeron A, Hengstenberg C, Engel S, Lowel H, Riegger GA, Schunkert H et al. The D-allele of the ACE polymorphism is related to increased QT dispersion in 609 patients after myocardial infarction. Eur Heart J 2001;22:663-8.
49. Zankov DP, Omatsu-Kanbe M, Isono T, Toyoda F, Ding WG, Matsuura H et al. Angiotensin II potentiates the slow component of delayed rectifier K+ current via the AT1 receptor in guinea pig atrial myocytes. Circulation 2006;113:1278-86.
50. Gilat E, Girouard SD, Pastore JM, Laurita KR, Rosenbaum DS. Angiotensin-converting enzyme inhibition produces electrophysiologic but not antiarrhythmic effects in the intact heart. J Cardiovasc Pharmacol 1998;31:734-40.